153 related articles for article (PubMed ID: 8688336)
1. Cancer incidence in the first-degree relatives of ovarian cancer patients.
Auranen A; Pukkala E; Mäkinen J; Sankila R; Grénman S; Salmi T
Br J Cancer; 1996 Jul; 74(2):280-4. PubMed ID: 8688336
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.
Kotaniemi-Talonen L; Pukkala E; Aittomäki K; Auranen A
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):240-245. PubMed ID: 36645194
[TBL] [Abstract][Full Text] [Related]
6. Familial clustering of ovarian and endometrial cancers.
Hemminki K; Granström C
Eur J Cancer; 2004 Jan; 40(1):90-5. PubMed ID: 14687794
[TBL] [Abstract][Full Text] [Related]
7. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
8. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
[TBL] [Abstract][Full Text] [Related]
9. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
10. Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study.
Bergfeldt K; Rydh B; Granath F; Grönberg H; Thalib L; Adami HO; Hall P
Lancet; 2002 Sep; 360(9337):891-4. PubMed ID: 12354469
[TBL] [Abstract][Full Text] [Related]
11. Population-based cohort investigations of the risk for malignant tumors in first-degree relatives and wives of men with breast cancer.
Olsson H; Andersson H; Johansson O; Möller TR; Kristoffersson U; Wenngren E
Cancer; 1993 Feb; 71(4):1273-8. PubMed ID: 8435804
[TBL] [Abstract][Full Text] [Related]
12. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families.
Sellers TA; King RA; Cerhan JR; Chen PL; Grabrick DM; Kushi LH; Oetting WS; Vierkant RA; Vachon CM; Couch FJ; Therneau TM; Olson JE; Pankratz VS; Hartmann LC; Anderson VE
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1051-7. PubMed ID: 10613336
[TBL] [Abstract][Full Text] [Related]
13. Borderline ovarian tumors in Finland: epidemiology and familial occurrence.
Auranen A; Grénman S; Mäkinen J; Pukkala E; Sankila R; Salmi T
Am J Epidemiol; 1996 Sep; 144(6):548-53. PubMed ID: 8797514
[TBL] [Abstract][Full Text] [Related]
14. Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Office of Population Censuses and Surveys.
Easton DF; Matthews FE; Ford D; Swerdlow AJ; Peto J
Int J Cancer; 1996 Jan; 65(3):284-94. PubMed ID: 8575846
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
16. Excess breast cancer risk in first degree relatives of CHEK2∗1100delC positive familial breast cancer cases.
Adank MA; Verhoef S; Oldenburg RA; Schmidt MK; Hooning MJ; Martens JW; Broeks A; Rookus M; Waisfisz Q; Witte BI; Jonker MA; Meijers-Heijboer H
Eur J Cancer; 2013 May; 49(8):1993-9. PubMed ID: 23415889
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
18. Incidence and mortality in epithelial ovarian cancer by family history of any cancer.
Hemminki K; Sundquist J; Brandt A
Cancer; 2011 Sep; 117(17):3972-80. PubMed ID: 21365633
[TBL] [Abstract][Full Text] [Related]
19. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
[TBL] [Abstract][Full Text] [Related]
20. The genetic attributable risk of breast and ovarian cancer.
Claus EB; Schildkraut JM; Thompson WD; Risch NJ
Cancer; 1996 Jun; 77(11):2318-24. PubMed ID: 8635102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
